Condition: Multiple Myeloma (MM) · Hematologic Neoplasm · Sponsor: Azienda USL Reggio Emilia - IRCCS
Individuals with multiple myeloma (MM) are vulnerable because of the effects of systemic organ damage and the side effects of treatment. A decline in patients' health-related quality of life (HRQoL) and a compromised participation in everyday life was reported. The diagnosis of MM negatively affects the principal informal caregiver. This is a concurrent exploratory mixed methods study that involves the use of a quantitative and a qualitative approach. For the quantitative study, aims are to describe any possible relation between the identified factors with HRQoL and participation in individuals with MM and with reactions to caring and self-efficacy of caregivers. For the qualitative study, aims are to investigate "how" and "why" the disease impacts the daily life of individuals with MM and their caregivers. The final analyses will be based on the comparison of the results of the quantitative phase and the results of the qualitative phase.
This description comes directly from the study's public registry record.
Sara Paltrinieri, PhD, OT · 0039 0522 522416 · sara.paltrinieri@ausl.re.it
Stefania Costi, PhD, PT · 0039 0522 522441 · stefania.costi@unimore.it
Always discuss trial participation with your own doctor first.
| Azienda Unità Sanitaria Locale Reggio Emilia - IRCCS | Reggio Emilia, RE, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07014865